semaglutide compound discontinued versions of GLP-1 drugs for weight loss halted by FDA Weight Watchers discontinued compound semaglutide.

It's worth tracking for a week or two to confirm your own pattern

It can increase the amount of growth hormone released by stimulating the pituitary gland with a large amount of additional growth hormones

[(accessed on 8 October 2024)]

This temporal pattern is consistent with the well-described phenomenon of GI adaptation to GLP-1 receptor activation, in which chronic receptor stimulation leads to desensitization of the vagal afferent pathways that mediate nausea and the enteric nervous system circuits that regulate gastric emptying and motility

Using medication beyond its recommended in-use period may result in reduced efficacy or increased risk of contamination